Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia

NCT ID: NCT03285204

Last Updated: 2019-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-07-31

Study Completion Date

2020-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to obtain an early biomarker of amyotrophic lateral sclerosis and Friedreich's Ataxia which allows to diagnose the disease in an initial stage and to follow up the patient with optic coherence tomography, a fast, non-invasive and comfortable method

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients will be asked about their data and their general medical history, and will be underwent on one hand, a complete neurological examination including the degree of neurological impairment quantified according to the functional rating scale of ALS (ALSFRS-r) or Scale for the assessment and rating of ataxia (SARA); On the other hand, they will have a complete ophthalmological examination too, including the patient's graduation, pupillary and ocular motility examination, biomicroscopy, Goldman tonometry and fundus exam. Patients will be performed too a conventional automated Humprey perimetry, color test (Farnsworth-Munsell 28 Hue Color Vision Test) and finally an optical coherence tomography (OCT) in order to see possible anatomical alterations in both macula and optic nerve. The follow-up of these explorations will be repeated in all cases at 6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amyotrophic Lateral Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ALS patients

No interventions assigned to this group

Friedreich Ataxia patients

No interventions assigned to this group

Healthy control

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Older than 18 years.
* Best corrected visual acuity more than 0.4 (20/50 Snellen = 0.4 logMAR = 65 ETDRS letters).
* Refractive defect less than 5 diopters of spherical equivalent and / or cylinder less than 2 diopters.
* Transparent optical media: Opacity of crystalline \<1 according to Lens Opacities Classification System (LOCS) III.
* Open anterior chamber angle assessed by gonioscopy with Goldmann lens (grade\> III).
* Availability and collaboration to carry out the tests of the exploratory protocol.
* Acceptance of informed consent.

* Mental retardation or any other limitation in obtaining informed consent.

Exclusion Criteria

* Previous intraocular surgeries of less than 6 months of evolution. Patients with refractive surgery using the LASIK or LASEK technique will not be excluded.
* Physical or mental difficulties to perform reliable and reproducible perimeters.
* Pathology and / or ocular malformations, angular or optic nerve anomalies.
* Any retinopathy or maculopathy.
* Intraocular pressure (IOP)\> 21 mmHg.
* Signal-to-noise ratio in OCT less than 5/10.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jose Luis Urcelay Segura

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jose Luis Urcelay Segura

Head Of ophthalmology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose L Urcelay, PhD

Role: PRINCIPAL_INVESTIGATOR

HGU Gregorio Marañón

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pilar Rojas Lozano

Madrid, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pilar Rojas, MD

Role: CONTACT

+34616042758

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pilar Rojas Lozano

Role: primary

+34616042758

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ELA-AF-OCT-2014-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Visual Rehabilitation After Occipital Stroke
NCT04798924 ACTIVE_NOT_RECRUITING NA
Visual Motor Coordination
NCT00568243 TERMINATED
Intermediate Visual Space Perception
NCT05419713 RECRUITING NA